1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Earnings

OTC COVID-19 Tests Have Abbott Seeing Continuing Demand For At-Home Diagnostics

 
• By Malcolm Spicer

“We see this is a as a significant opportunity, and quite frankly, a trend that's been happening overseas and is kind of now happening here in the US,” says Abbott Labs CEO Robert Ford.

Abbott Labs recently started shipping its BinaxNOW COVID-19 Ag Self Test to US retailers.

The coronavirus pandemic prompted Abbott Laboratories Ltd.’s development of an OTC test for the COVID-19, meeting consumer demand that it anticipates will continue and make diagnostic tests common items in US medicine cabinets.

“We see this is a as a significant opportunity, and quite frankly, a trend that's been happening overseas and is...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

Kenvue Makes CEO Change Months After Critical Activist Investor Made Proxy Play For Board Seat

Thibaut Mongon is out as Kenvue CEO, a post he’s held since J&J spun it out in July 2023, after the firm’s results came under increased investor scrutiny over the past year. The board appointed as interim CEO Kirk Perry, a board member since December who most recently headed technology, data and pre

Perrigo Combines Americas, International Leads Into Global Post In Latest Move To Boost Results

 
• By Malcolm Spicer

Roberto Khoury, Perrigo’s international lead for a year, moves to CCO while his counterpart for the Americas region appointed in September 2023, Catherine "Triona" Schmelter, is leaving with her post eliminated in the firm’s changes.

Acquisitions Help Spain’s Uriach Grow Sales By More Than 50%

 
• By Tom Gallen

European consumer health player Uriach records sales approaching €500m in 2024 after completing acquisitions which took the firm into new markets.

Stada Held Back By Weak Cough & Cold Season

 
• By Tom Gallen

While sales of seasonal products struggled during Q1, Stada pointed to the continuing strength of its underlying Consumer Healthcare portfolio.

More from Business

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.

Lupin Goes For Growth With Indian Consumer Health Spin-Off

 
• By Tom Gallen

With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.

US Tariff Overhang Weighs on Chinese API Exports

 
• By Dexter Jie Yan

Chinese API exports to US fell 24% year-on-year to $255m in May, when US and China called a truce in a previously escalating trade war.